News
About half of patients with asthma on tezepelumab had discontinued their daily maintenance oral corticosteroid doses by 52 ...
1d
News-Medical.Net on MSNEarly allergen introduction reduces childhood food allergy riskInvestigating allergy prevention, this research highlights early intervention strategies and the promise of biologic ...
Fact: Symptoms can vary. “Breathlessness, chest tightness & coughing also matter,” says Dr Divya Shree J, Consultant – ...
Discover a study that found that tezepelumab also showed promise in patients previously unresponsive to other biologics.
Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...
The FDA warns that longtime users of popular allergy medications may experience "severe itching" after stopping use.
As spring blooms in May, weed pollen peaks—triggering allergies for millions. Explore the science behind this reaction and ...
The risk for fertility treatment rose among women with vs. without asthma, and those with severe asthma and past ...
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results